C12Y 302/01127
1,6-alpha-l-fucosidase
Official title: 1,6-alpha-L-fucosidase (3.2.1.127)
C12Y302/01127 (1,6-alpha-l-fucosidase) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 3
- Assignees
- 4
- Inventors
- 9
- Latest grant
- 26 Dec 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
By publication year.
Recent patents
- Fusion protein for remodeling antibody glycoform26 Dec 2023US 11,851,691 B2Cho Pharma, Inc.
- Designer α 6-fucosidase mutants enable direct core fucosylation of intact N-glycopeptides and N-glycoproteins7 Dec 2021US 11,193,155 B2University of Maryland, College Park
- Cleavage of fucose in N-glycans16 Apr 2019US 10,260,056 B2New England Biolabs, Inc.
- Fusion protein for remodeling antibody glycoform11 Feb 2021US 2021/0040463 A1Cho Pharma, Inc.
- Designer alpha 6-fucosidase mutants enable direct core fucosylation of intact n-glycopeptides and n-glycoproteins20 Jun 2019US 2019/0185898 A1University of Maryland, Baltimore County
- Cleavage of Fucose in N-Glycans20 Sep 2018US 2018/0265854 A1New England Biolabs, Inc.
Most cited
By later US patents